In Vivo Delivery of Nucleic Acid-Formulated Microparticles as a Potential Tolerogenic Vaccine for Type 1 Diabetes . Rev Diabet Stud [Internet]. 2023 Aug. 12 [cited 2025 Sep. 13];9(4). Available from: https://diabeticstudies.org/index.php/RDS/article/view/184